Skip to search formSkip to main contentSkip to account menu

cycrimine

Known as: Cycriminum, Cicrimina, alpha-cyclopentyl-alpha-phenyl-1-piperidinepropanol.HCl 
National Institutes of Health

Related topics

Related topics

2 relations
CYCRIMINE HCL

Broader (1)

Piperidines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Synthetic method of cyclopentyl pyrimido pyrroles compound
The invention discloses a synthetic method of a cyclopentyl pyrimido pyrroles compound, which belongs to the field of organic… 
2013
2013
X-Ray Crystallographic analysis of Fungicide monceren N-((4-chlorophenyl)methyl)-N-cyclopentyl-N'-phenylurea
Monceren N-((4-chlorophenyl)methyl)-N-cyclopentyl-N'-phenylurea, a local Non systemic fungicide with good protectant The activity… 
2013
2013
[Inhibitory effect on Microcystis aeruginosa as well as separation and identification of the allelochemicals of welsh onion].
OBJECTIVE To study the inhibition of welsh onion on Microcystis aeruginosa, and separat and identify of the allelochemicals from… 
2009
2009
Palladium(II) complexes with R2edda-derived ligands. Part II. Synthesis, characterization and in vitro antitumoral studies of R2eddip esters and palladium(II) complexes.
2007
2007
Nucleophilic reaction of cyclopentylamine on phthalimide derivatives: synthesis and antinociceptive activity of products.
The reaction of cyclopentylamine with N-prop-2-ynylphthalimde la and 4-phthalimidobutyric acid 1b was carried out in… 
1996
1996
Heteroligation of a mouse monoclonal IgE antibody (La2) with small molecules, analysed by computer-aided automated docking.
1989
1989
Capillary gas chromatography of trihexyphenidyl, procyclidine and cycrimine in biological fluids.
1981
1981
Interrelationship between anticonvulsant and enzyme inhibitory properties of N-methyl-N-2-[1-(1-arylthiocarbamido)] cyclopentyl nitrobenzamides.
1977
1977
Interactions of some cholinolytic anti-parkinson drugs with nicotine and oxotremorine on rat diaphragm.
1966
1966
Identification and differentiation of organic medicinal agents. 3. Amine-containing antiparkinson agents and newer muscle relaxants.
A series of specific physical criteria, by which four amine-containing antiparkinson agents and a newer amine-containing skeletal… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)